Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.5B | 9.6B | 9.9B | 9.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.1B | 1.9B | 2.3B | 2.3B |
Other operating expenses | 1.4B | 2.6B | 1.1B | 414.6M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 5.0B | 4.5B | 4.7B | 4.1B |
Tax provision | 845.7M | 521.1M | 632.7M | 605.5M |
Net income | 3.4B | 3.2B | 3.4B | 2.9B |
Basic EPS | 0.3 | — | — | — |
Diluted EPS | 0.3 | — | — | — |
Basic average shares | 11.5B | — | — | — |
Diluted average shares | 11.5B | — | — | — |
EBITDA | — | — | — | — |
Net income from continuing op. | 3.2B | 3.1B | 3.1B | 2.8B |
Minority interests | -201.3M | -96.1M | -295.2M | -29.9M |
Preferred stock dividends | — | — | — | — |